These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2171719)

  • 21. Effect of DSP-4, a noradrenergic neurotoxin, on sleep and wakefulness and sensitivity to drugs acting on adrenergic receptors in the rat.
    Monti JM; D'Angelo L; Jantos H; Barbeito L; Abó V
    Sleep; 1988 Aug; 11(4):370-7. PubMed ID: 2849796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electroencephalographic study of the effect of neurotoxin DSP-4 in iron model of chronic focal epilepsy.
    Sharma V; Singh R
    Indian J Exp Biol; 1999 May; 37(5):468-75. PubMed ID: 10492619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-(2-Chloroethyl)-N-ethyl-2-bromobenzylamine reduces intracellular calcium response to noradrenaline in rat visual cortex.
    Yamamoto M; Imamura K; Kobayashi M; Nakadate K; Yokoyama C; Watanabe Y; Yamamoto M; Negi A
    Neuroscience; 2001; 107(2):209-18. PubMed ID: 11731095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spatial learning and noradrenaline content in the brain and periphery of young and aged rats.
    Sirviö J; Lahtinen H; Riekkinen P; Riekkinen PJ
    Exp Neurol; 1994 Feb; 125(2):312-5. PubMed ID: 8313947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical evaluation of McN-5707 as a potential antidepressant.
    Shank RP; Gardocki JF; Schneider CR; Vaught JL; Setler PE; Maryanoff BE; McComsey DF
    J Pharmacol Exp Ther; 1987 Jul; 242(1):74-84. PubMed ID: 3039115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in drug induced catalepsy and post-decapitation convulsions following brain and spinal cord depletion of norepinephrine by the neurotoxin DSP-4.
    Asin KE; Wirtshafter D; Fibiger HC
    Life Sci; 1982 May; 30(18):1531-6. PubMed ID: 7200562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Facilitation of shock-induced fighting in the rat after DSP-4, a selective noradrenergic neurotoxin.
    Mogilnicka E; Dooley DJ; Boissard CG; Delini-Stula A
    Pharmacol Biochem Behav; 1983 Apr; 18(4):625-8. PubMed ID: 6602990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central noradrenergic activity affects analgesic effect of Neuropeptide S.
    Jinushi K; Kushikata T; Kudo T; Calo G; Guerrini R; Hirota K
    J Anesth; 2018 Feb; 32(1):48-53. PubMed ID: 29128909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional supersensitivity to adrenergic agonists in the rat after DSP-4, a selective noradrenergic neurotoxin.
    Dooley DJ; Mogilnicka E; Delini-Stula A; Waechter F; Truog A; Wood J
    Psychopharmacology (Berl); 1983; 81(1):1-5. PubMed ID: 6415724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the noradrenergic neurotoxin DSP-4 on the expression of α1-adrenoceptor subtypes after antidepressant treatment.
    Kreiner G; Zelek-Molik A; Kowalska M; Bielawski A; Antkiewicz-Michaluk L; Nalepa I
    Pharmacol Rep; 2011; 63(6):1349-58. PubMed ID: 22358083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered hindlimb extension in the rat after DSP-4: a useful marker of central noradrenergic depletion.
    Mogilnicka E; Dooley DJ; Boissard CG; Delini-Stula A
    Eur J Pharmacol; 1983 Feb; 87(2-3):345-7. PubMed ID: 6840195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain noradrenaline and the development of hypertension: the effect of treatment with central 6-hydroxydopamine or DSP-4.
    van den Buuse M; Versteeq DH; de Jong W
    Clin Exp Pharmacol Physiol; 1986 Jun; 13(6):469-76. PubMed ID: 3093124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the noradrenergic neurotoxin DSP-4 on luteinizing hormone levels, catecholamine concentrations, alpha 2-adrenergic receptor binding, and aromatase activity in the brain of the Japanese quail.
    Balthazart J; Ball GF
    Brain Res; 1989 Jul; 492(1-2):163-75. PubMed ID: 2568873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of central noradrenergic function by RS-15385-197.
    Redfern WS; MacKinnon AC; Brown CM; Martin AB; Kilpatrick AT; Clague RU; Spedding M
    Br J Pharmacol; 1993 Feb; 108(2):526-33. PubMed ID: 8095421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [3H]nisoxetine: a new radioligand for norepinephrine uptake sites in brain.
    Tejani-Butt SM; Brunswick DJ; Frazer A
    Eur J Pharmacol; 1990 Nov; 191(2):239-43. PubMed ID: 2086242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Noradrenergic Neurotoxin DSP-4 and Maprotiline on Heart Rate Spectral Components in Stressed and Resting Rats.
    Kur'yanova EV; Zhukova YD; Teplyi DL
    Bull Exp Biol Med; 2017 Jul; 163(3):302-306. PubMed ID: 28744642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-dependent interactive changes in serotonergic and noradrenergic cortical axon terminals in F344 rats.
    Nakai S; Matsunaga W; Isobe K; Shirokawa T
    Neurosci Res; 2006 Mar; 54(3):220-9. PubMed ID: 16406149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noradrenergic denervation attenuates desipramine enhancement of aggressive behavior in isolated mice.
    Matsumoto K; Ojima K; Watanabe H
    Pharmacol Biochem Behav; 1995 Mar; 50(3):481-4. PubMed ID: 7617690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of the central noradrenergic system in cholinergic stimulation of the pituitary-adrenal response.
    Bugajski J; Borycz J; Gadek-Michalska A
    J Physiol Pharmacol; 1998 Jun; 49(2):285-92. PubMed ID: 9670111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Competition by monophenolic estrogens and catecholestrogens for high-affinity uptake of [3H](-)-norepinephrine into synaptosomes from rat cerebral cortex and hypothalamus.
    Ghraf R; Michel M; Hiemke C; Knuppen R
    Brain Res; 1983 Oct; 277(1):163-8. PubMed ID: 6315138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.